Lipoprotein(a) (Lp[a]) is an independent risk factor for coronary artery disease, and the presence of other risk factors serves as a further amplifier of risk. Researchers presented clinical studies of Lp(a)-lowering agents and addressed these and related issues at the recent American College of Cardiology 74th Annual Scientific Session & Expo (ACC.25). Following these presentations, featured expert Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI, was interviewed by Conference Reporter Associate

Lipoprotein(a) (Lp[a]) is an independent risk factor for coronary artery disease, and the presence of other risk factors serves as a further amplifier of risk. Researchers presented clinical studies of Lp(a)-lowering agents and addressed these and related issues at the recent American College of Cardiology 74th Annual Scientific Session & Expo (ACC.25). Following these presentations, featured expert Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI, was interviewed by Conference Reporter Associate

Lipoprotein(a) (Lp[a]) is an independent risk factor for coronary artery disease, and the presence of other risk factors serves as a further amplifier of risk. Researchers presented clinical studies of Lp(a)-lowering agents and addressed these and related issues at the recent American College of Cardiology 74th Annual Scientific Session & Expo (ACC.25). Following these presentations, featured expert Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI, was interviewed by Conference Reporter Associate